Literature DB >> 12482804

Tumour necrosis factor alpha concentration and collateral flow in patients with coronary artery disease and normal systolic left ventricular function.

C Seiler, T Pohl, M Billinger, B Meier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12482804      PMCID： PMC1767515          DOI： 10.1136/heart.89.1.96

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

Authors:  M Fràter-Schröder; W Risau; R Hallmann; P Gautschi; P Böhlen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

2.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.

Authors:  S J Leibovich; P J Polverini; H M Shepard; D M Wiseman; V Shively; N Nuseir
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

3.  Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis.

Authors:  S Yoshida; M Ono; T Shono; H Izumi; T Ishibashi; H Suzuki; M Kuwano
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

4.  Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements.

Authors:  C Seiler; M Fleisch; A Garachemani; B Meier
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

5.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G Torre-Amione; S Kapadia; C Benedict; H Oral; J B Young; D L Mann
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094
  5 in total
  3 in total

1.  Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion.

Authors:  Ying Shen; Feng Hua Ding; Rui Yan Zhang; Qi Zhang; Lin Lu; Wei Feng Shen
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

2.  Predictors of poor coronary collateral development in patients with stable coronary artery disease: neutrophil-to-lymphocyte ratio and platelets.

Authors:  Fatih Akın; Burak Ayça; Ömer Çelik; Cem Şahin
Journal:  Anatol J Cardiol       Date:  2014-04-08       Impact factor: 1.596

Review 3.  Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Feng Hua Ding; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Lin Lu; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-02-08       Impact factor: 9.951
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.